Bupivacaine Hydrochloride Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Bupivacaine Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Feb 20, 2018.

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-0525-25
Dosage Form
Injection
Presentation
Marcaine, Injection, 250 mg/50 mL (NDC 0409-0525-25)
Initial Posting
Feb 20, 2018

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.